Search research articles
Contact Us
Filters
Showing results (651-660 of 686) with videos related to
Page
of 69
Sort By:
Chemico-Biological Interactions
|
May 11, 2026
Saroglitazar, a novel PPAR-α/γ agonist, modulates thyroid hormone homeostasis through hepatic UGT expression in wistar rats
Praveen Kumar Jain, Laxit K Bhatt, Ashvin K Patel, et al.
Cancer Chemotherapy and Pharmacology
|
July 27, 2018
Identification and preclinical characterization of a novel and potent poly (ADP-ribose) polymerase (PARP) inhibitor ZYTP1
Mukul R Jain, Jogeswar Mohapatra, Debdutta Bandhyopadhyay, et al.
Circulation
|
May 4, 2012
Influence of mitral regurgitation repair on survival in the surgical treatment for ischemic heart failure trial
Marek A Deja, Paul A Grayburn, Benjamin Sun, et al.
Clinical Pharmacokinetics
|
May 17, 2017
Phase I Clinical Study of ZYAN1, A Novel Prolyl-Hydroxylase (PHD) Inhibitor to Evaluate the Safety, Tolerability, and Pharmacokinetics Following Oral Administration in Healthy Volunteers
Kevinkumar A Kansagra, Deven Parmar, Rajendra H Jani, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
November 19, 2015
Role of vascular density and normalization in response to neoadjuvant bevacizumab and chemotherapy in breast cancer patients
Sara M Tolaney, Yves Boucher, Dan G Duda, et al.
Chemmedchem
|
December 16, 2014
Optimization of 1,2,5-thiadiazole carbamates as potent and selective ABHD6 inhibitors
Jayendra Z Patel, Tapio J Nevalainen, Juha R Savinainen, et al.
Bioorganic & Medicinal Chemistry Letters
|
January 22, 2008
Bioisosteric replacement of dihydropyrazole of 4S-(-)-3-(4-chlorophenyl)-N-methyl-N'-[(4-chlorophenyl)-sulfonyl]-4-phenyl-4,5-dihydro-1H-pyrazole-1-caboxamidine (SLV-319) a potent CB1 receptor antagonist by imidazole and oxazole
Brijesh Kumar Srivastava, Rina Soni, Amit Joharapurkar, et al.
Vaccines
|
September 27, 2025
Peptide-Based Anti-PCSK9 Product for Long-Lasting Management of Hypercholesterolemia
Suresh R Giri, Akshyaya Chandan Rath, Chitrang J Trivedi, et al.
AJNR. American Journal of Neuroradiology
|
September 9, 2017
Diagnostic Accuracy of Neuroimaging to Delineate Diffuse Gliomas within the Brain: A Meta-Analysis
N Verburg, F W A Hoefnagels, F Barkhof, et al.
Bioorganic & Medicinal Chemistry
|
August 1, 1997
Anti-invasive activity of alkaloids and polyphenolics in vitro
V S Parmar, M E Bracke, J Philippe, et al.
Page
of 69
Search research articles
Search
Showing results (651-660 of 686) with videos related to
Sort By:
Page
of 69
Chemico-Biological Interactions
|
May 11, 2026
Saroglitazar, a novel PPAR-α/γ agonist, modulates thyroid hormone homeostasis through hepatic UGT expression in wistar rats
Praveen Kumar Jain, Laxit K Bhatt, Ashvin K Patel, et al.
Cancer Chemotherapy and Pharmacology
|
July 27, 2018
Identification and preclinical characterization of a novel and potent poly (ADP-ribose) polymerase (PARP) inhibitor ZYTP1
Mukul R Jain, Jogeswar Mohapatra, Debdutta Bandhyopadhyay, et al.
Circulation
|
May 4, 2012
Influence of mitral regurgitation repair on survival in the surgical treatment for ischemic heart failure trial
Marek A Deja, Paul A Grayburn, Benjamin Sun, et al.
Clinical Pharmacokinetics
|
May 17, 2017
Phase I Clinical Study of ZYAN1, A Novel Prolyl-Hydroxylase (PHD) Inhibitor to Evaluate the Safety, Tolerability, and Pharmacokinetics Following Oral Administration in Healthy Volunteers
Kevinkumar A Kansagra, Deven Parmar, Rajendra H Jani, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
November 19, 2015
Role of vascular density and normalization in response to neoadjuvant bevacizumab and chemotherapy in breast cancer patients
Sara M Tolaney, Yves Boucher, Dan G Duda, et al.
Chemmedchem
|
December 16, 2014
Optimization of 1,2,5-thiadiazole carbamates as potent and selective ABHD6 inhibitors
Jayendra Z Patel, Tapio J Nevalainen, Juha R Savinainen, et al.
Bioorganic & Medicinal Chemistry Letters
|
January 22, 2008
Bioisosteric replacement of dihydropyrazole of 4S-(-)-3-(4-chlorophenyl)-N-methyl-N'-[(4-chlorophenyl)-sulfonyl]-4-phenyl-4,5-dihydro-1H-pyrazole-1-caboxamidine (SLV-319) a potent CB1 receptor antagonist by imidazole and oxazole
Brijesh Kumar Srivastava, Rina Soni, Amit Joharapurkar, et al.
Vaccines
|
September 27, 2025
Peptide-Based Anti-PCSK9 Product for Long-Lasting Management of Hypercholesterolemia
Suresh R Giri, Akshyaya Chandan Rath, Chitrang J Trivedi, et al.
AJNR. American Journal of Neuroradiology
|
September 9, 2017
Diagnostic Accuracy of Neuroimaging to Delineate Diffuse Gliomas within the Brain: A Meta-Analysis
N Verburg, F W A Hoefnagels, F Barkhof, et al.
Bioorganic & Medicinal Chemistry
|
August 1, 1997
Anti-invasive activity of alkaloids and polyphenolics in vitro
V S Parmar, M E Bracke, J Philippe, et al.
Page
of 69